Share Capital (Tables)
|
12 Months Ended |
Dec. 31, 2022 |
|---|
| Share Capital [Abstract] |
|
| Schedule of shares issued granted options |
| |
|
Year ended December 31, 2022 |
|
|
| |
|
Award amount |
|
|
Exercise
price range |
|
|
Vesting
period |
|
Expiration |
| Employees |
|
|
529,000 |
|
|
$ |
5.33-9.22 |
|
|
4 years |
|
10 years |
| Directors |
|
|
217,000 |
|
|
$ |
9.22 |
|
|
4 years |
|
10 years |
| |
|
Year ended December 31, 2021 |
|
|
| |
|
Award amount |
|
|
Exercise
price range |
|
|
Vesting
period |
|
Expiration |
| Employees |
|
|
96,500 |
|
|
$ |
12.78-20.7 |
|
|
4 years |
|
10 years |
| Directors |
|
|
23,000 |
|
|
$ |
15.2 |
|
|
4 years |
|
10 years |
| |
|
Year
ended December 31, 2020 |
|
|
| |
|
Award amount |
|
|
Exercise
price range |
|
|
Vesting
period |
|
Expiration |
| Employees |
|
|
317,909 |
|
|
$ |
10.08 |
|
|
4 years |
|
10 years |
| Directors |
|
|
194,713 |
|
|
$ |
9.12-11.06 |
|
|
4 years |
|
10 years |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Schedule of fair value of options granted to employees on the date of grant was computed using the Black-Scholes model |
| |
|
Year ended December 31, |
|
| |
|
2022 |
|
|
2021 |
|
|
2020 |
|
| Value of one ordinary share |
|
$ |
5.03-9.22 |
|
|
$ |
11.9-20.37 |
|
|
$ |
7.86-10.5 |
|
| Dividend yield |
|
|
0 |
% |
|
|
0 |
% |
|
|
0 |
% |
| Expected volatility |
|
|
67.95-72.27 |
% |
|
|
65.36-66.49 |
% |
|
|
66.12-66.41 |
% |
| Risk-free interest rate |
|
|
0.39-3.03 |
% |
|
|
0.64-1.37 |
% |
|
|
0.45-0.52 |
% |
| Expected term |
|
|
6.11 years |
|
|
|
6.11 years |
|
|
|
6.11 years |
|
|
| Schedule of weighted average period |
| |
|
Year ended December 31, |
|
| |
|
2022 |
|
|
2021 |
|
|
2020 |
|
| Weighted-average grant date fair value of options granted, per option |
|
$ |
5.32 |
|
|
|
9.16 |
|
|
|
5.76 |
|
| Total intrinsic value of the options exercised |
|
|
221 |
|
|
|
869 |
|
|
|
82 |
|
| Total fair value of options vested |
|
|
2,802 |
|
|
|
3,356 |
|
|
|
1,937 |
|
|
| Schedule of changes in number of options granted |
| |
|
2022 |
|
| |
|
Number of
options |
|
|
Weighted
average
exercise
price |
|
|
weighted average remaining contractual term (in years) |
|
|
aggregate intrinsic value |
|
| Options outstanding at the beginning of the year |
|
|
1,220,694 |
|
|
$ |
7.71 |
|
|
|
5.84 |
|
|
$ |
7,445 |
|
| Granted |
|
|
746,000 |
|
|
|
8.54 |
|
|
|
|
|
|
|
|
|
| Exercised |
|
|
(39,457 |
) |
|
|
4.42 |
|
|
|
|
|
|
|
|
|
| Expired |
|
|
(3,438 |
) |
|
|
10.39 |
|
|
|
|
|
|
|
|
|
| Forfeited |
|
|
(55,050 |
) |
|
|
11.48 |
|
|
|
|
|
|
|
|
|
| Options outstanding at the end of the year |
|
|
1,868,749 |
|
|
|
7.85 |
|
|
|
6.81 |
|
|
|
14,818 |
|
| Options exercisable at the end of the year |
|
|
914,373 |
|
|
$ |
6.79 |
|
|
|
4.34 |
|
|
$ |
6,209 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
2022 |
|
| |
|
Number of
options |
|
|
Weighted
average
exercise
price |
|
|
weighted average remaining contractual term (in years) |
|
|
aggregate intrinsic value |
|
| Options outstanding at the beginning of the year |
|
|
15,416 |
|
|
$ |
16.04 |
|
|
|
2.54 |
|
|
|
314 |
|
| Options outstanding at the end of the year |
|
|
15,416 |
|
|
$ |
16.04 |
|
|
|
1.79 |
|
|
|
202 |
|
| Options exercisable at the end of the year |
|
|
9,766 |
|
|
$ |
8.47 |
|
|
|
1.52 |
|
|
|
65 |
|
|
| Schedule of outstanding and exercisable options |
| December 31, 2022 |
|
| Options outstanding |
|
|
Options exercisable |
|
| Exercise prices * |
|
|
Number of
options
outstanding
at end of year |
|
|
Weighted
average
remaining
contractual Life |
|
|
Number of
options
exercisable
at end of year |
|
|
Weighted
average
remaining
contractual life |
|
| $ |
25.58 |
|
|
|
6,666 |
|
|
|
2.38 |
|
|
|
1,329 |
|
|
|
2.38 |
|
| |
6.25 |
|
|
|
5,000 |
|
|
|
2.33 |
|
|
|
5,000 |
|
|
|
2.33 |
|
| |
15.2 |
|
|
|
23,000 |
|
|
|
8.41 |
|
|
|
8,625 |
|
|
|
8.41 |
|
| |
13.08 |
|
|
|
31,375 |
|
|
|
7.56 |
|
|
|
14,777 |
|
|
|
7.02 |
|
| |
12.78 |
|
|
|
30,000 |
|
|
|
8.24 |
|
|
|
13,125 |
|
|
|
8.24 |
|
| |
11.06 |
|
|
|
162,713 |
|
|
|
7.11 |
|
|
|
111,865 |
|
|
|
7.11 |
|
| |
10.08 |
|
|
|
286,198 |
|
|
|
7.19 |
|
|
|
183,303 |
|
|
|
7.06 |
|
| |
9.12 |
|
|
|
32,000 |
|
|
|
7.66 |
|
|
|
18,000 |
|
|
|
7.66 |
|
| |
5.07 |
|
|
|
188,625 |
|
|
|
3.04 |
|
|
|
175,277 |
|
|
|
3.04 |
|
| |
4.02 |
|
|
|
396,588 |
|
|
|
2.22 |
|
|
|
392,838 |
|
|
|
2.2 |
|
| |
9.22 |
|
|
|
591,000 |
|
|
|
9.22 |
|
|
|
- |
|
|
|
- |
|
| $ |
5.33 |
|
|
|
131,000 |
|
|
|
9.92 |
|
|
|
- |
|
|
|
- |
|
| |
|
|
|
|
1,884,165 |
|
|
|
|
|
|
|
924,139 |
|
|
|
|
|
|
* |
In U.S. dollars per Ordinary Share. |
|
| Schedule of share-based compensation |
| |
|
Year ended December 31 |
|
| |
|
2022 |
|
|
2021 |
|
|
2020 |
|
| Cost of revenues |
|
$ |
22 |
|
|
$ |
78 |
|
|
$ |
66 |
|
| Research and development expenses |
|
|
565 |
|
|
|
525 |
|
|
|
464 |
|
| General, administrative and marketing expenses |
|
|
1,587 |
|
|
|
1,017 |
|
|
|
1,075 |
|
| |
|
$ |
2,174 |
|
|
$ |
1,620 |
|
|
$ |
1,605 |
|
|